Nodular non-suppurative panniculitis
diseaseOn this page
Also known as idiopathic lobular panniculitisidiopathic nodular panniculitisnodular nonsuppurative panniculitispanniculitis nodular nonsuppurativePfeiffer-Weber-Christian syndromeRelapsing febrile nodular nonsuppurative panniculitisRelapsing febrile nodular panniculitisWCDWeber Christian diseaseWeber-Christian diseaseWeber-Christian panniculitis
Summary
Nodular non-suppurative panniculitis (MONDO:0018063) is a disease. A subtype of panniculitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 15
Clinical features
Signs & symptoms
Clinical features (HPO)
15 HPO clinical features (Orphanet curated; top 15 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000969 | Edema | Very frequent (80-99%) |
| HP:0001482 | Subcutaneous nodule | Very frequent (80-99%) |
| HP:0001824 | Weight loss | Very frequent (80-99%) |
| HP:0001945 | Fever | Very frequent (80-99%) |
| HP:0002017 | Nausea and vomiting | Very frequent (80-99%) |
| HP:0002027 | Abdominal pain | Very frequent (80-99%) |
| HP:0002829 | Arthralgia | Very frequent (80-99%) |
| HP:0003326 | Myalgia | Very frequent (80-99%) |
| HP:0008065 | Aplasia/Hypoplasia of the skin | Very frequent (80-99%) |
| HP:0010783 | Erythema | Very frequent (80-99%) |
| HP:0012490 | Panniculitis | Very frequent (80-99%) |
| HP:0001744 | Splenomegaly | Occasional (5-29%) |
| HP:0002240 | Hepatomegaly | Occasional (5-29%) |
| HP:0002960 | Autoimmunity | Occasional (5-29%) |
| HP:0100533 | Inflammatory abnormality of the eye | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | nodular non-suppurative panniculitis |
| Mondo ID | MONDO:0018063 |
| EFO | EFO:1000742 |
| MeSH | D010201 |
| Orphanet | 33577 |
| DOID | DOID:1525 |
| SNOMED CT | 33760009 |
| UMLS | C0030328 |
| MedGen | 10559 |
| GARD | 0007879 |
| MedDRA | 10047883 |
| Is cancer (heuristic) | no |
Also known as: idiopathic lobular panniculitis · idiopathic nodular panniculitis · nodular nonsuppurative panniculitis · panniculitis nodular nonsuppurative · Pfeiffer-Weber-Christian syndrome · Relapsing febrile nodular nonsuppurative panniculitis · Relapsing febrile nodular panniculitis · WCD · Weber Christian disease · Weber-Christian disease · Weber-Christian panniculitis
Disease family
This is a subtype of panniculitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › panniculitis › nodular non-suppurative panniculitis
Related subtypes (5): panniculitis and localized lipodystrophy, lupus erythematosus panniculitis, cytophagic histiocytic panniculitis, lipodermatosclerosis, erythema nodosum
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.